Advertisement
Research Article| Volume 319, ISSUE 1-2, P15-17, August 15, 2012

Download started.

Ok

Impact of infections on long-term outcome after severe middle cerebral artery infarction

  • Author Footnotes
    1 These authors contributed equally to the manuscript.
    Lena Ulm
    Footnotes
    1 These authors contributed equally to the manuscript.
    Affiliations
    NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany

    Department of Neurology, Charité -Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to the manuscript.
    Hendrik Harms
    Footnotes
    1 These authors contributed equally to the manuscript.
    Affiliations
    NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
    Search for articles by this author
  • Stephanie Ohlraun
    Affiliations
    NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
    Search for articles by this author
  • Peter Reimnitz
    Affiliations
    Im Uckerfeld 2, 53127 Bonn, Germany
    Search for articles by this author
  • Andreas Meisel
    Correspondence
    Corresponding author at: Department of Neurology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. Tel.: +49 30 450 560 026; fax: +49 30 450 539 913.
    Affiliations
    NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany

    Department of Neurology, Charité -Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany

    Center for Stroke Research Berlin, Charité ‐Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to the manuscript.

      Abstract

      Post-stroke infections are the most important complications after acute stroke, accounting for almost 20% of in-hospital deaths and poor functional outcomes at discharge. Little is known about long-term effects of post-stroke infections on outcome. Here, we studied the impact of infections on long-term outcome in 64 patients which had suffered from severe middle cerebral artery infarction. Mean follow-up time in the survivors was 6.5±0.9 years. Structured telephone interviews were performed to assess the patients' current functional outcome. Where re-contacting was not successful, vital status of the patients was requested at the registration office of Berlin. Multiple logistic regression analysis identified three independent risk factors associated with mortality: infections within the first 11 days after stroke, age>64 years, and female sex. Among surviving patients, functional outcome measured by Barthel Index was influenced by infections and immunocompetence measured by levels of monocytic HLA-DR expression on day 3 after stroke. In conclusion, the occurrence of post-stroke infections is the most important predictor of poor long-term outcome in this cohort of patients. Our observation warrants prospective trials on prevention or early treatment of post-stroke infections in order to improve long-term outcome after stroke.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Koennecke H.C.
        • Belz W.
        • Berfelde D.
        • Endres M.
        • Fitzek S.
        • Hamilton F.
        • et al.
        Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit.
        Neurology. 2011; 77: 965-972
        • Westendorp W.F.
        • Nederkoorn P.J.
        • Vermeij J.D.
        • Dijkgraaf M.G.
        • van de Beek D.
        Post-stroke infection: a systematic review and meta-analysis.
        BMC Neurol. 2011; 11: 110
        • Finlayson O.
        • Kapral M.
        • Hall R.
        • Asllani E.
        • Selchen D.
        • Saposnik G.
        Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke.
        Neurology. 2011; 77: 1338-1345
        • Harms H.
        • Prass K.
        • Meisel C.
        • Klehmet J.
        • Rogge W.
        • Drenckhahn C.
        • et al.
        Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial.
        PLoS One. 2008; 3: e2158
        • Hankey G.J.
        Long-term outcome after ischaemic stroke/transient ischaemic attack.
        Cerebrovasc Dis. 2003; 16: 14-19
        • Fukuda M.
        • Kanda T.
        • Kamide N.
        • Akutsu T.
        • Sakai F.
        Gender differences in long-term functional outcome after first-ever ischemic stroke.
        Intern Med. 2009; 48: 967-973
        • Hilker R.
        • Poetter C.
        • Findeisen N.
        • Sobesky J.
        • Jacobs A.
        • Neveling M.
        • et al.
        Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine.
        Stroke. 2003; 34: 975-981
        • Meisel C.
        • Schwab J.M.
        • Prass K.
        • Meisel A.
        • Dirnagl U.
        Central nervous system injury-induced immune deficiency syndrome.
        Nat Rev Neurosci. 2005; 6: 775-786
        • Chamorro A.
        • Urra X.
        • Planas A.M.
        Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression.
        Stroke. 2007; 38: 1097-1103
        • Klehmet J.
        • Harms H.
        • Richter M.
        • Prass K.
        • Volk H.D.
        • Dirnagl U.
        • et al.
        Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial.
        Neuroscience. 2009; 158: 1184-1193
        • Prass K.
        • Meisel C.
        • Hoflich C.
        • Braun J.
        • Halle E.
        • Wolf T.
        • et al.
        Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.
        J Exp Med. 2003; 198: 725-736
        • Emsley H.C.
        • Hopkins S.J.
        Acute ischaemic stroke and infection: recent and emerging concepts.
        Lancet Neurol. 2008; 7: 341-353
        • Meisel C.
        • Prass K.
        • Braun J.
        • Victorov I.
        • Wolf T.
        • Megow D.
        • et al.
        Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke.
        Stroke. 2004; 35: 2-6
        • Westendorp W.F.
        • Vermeij J.D.
        • Vermeij F.
        • Den Hertog H.M.
        • Dippel D.W.
        • van de Beek D.
        • et al.
        Antibiotic therapy for preventing infections in patients with acute stroke.
        Cochrane Database Syst Rev. 2012; 1 (CD008530)
        • Nederkoorn P.J.
        • Westendorp W.F.
        • Hooijenga I.J.
        • de Haan R.J.
        • Dippel D.W.
        • Vermeij F.H.
        • et al.
        Preventive antibiotics in stroke study: rationale and protocol for a randomised trial.
        Int J Stroke. 2011; 6: 159-163
        • Urra X.
        • Cervera A.
        • Obach V.
        • Climent N.
        • Planas A.M.
        • Chamorro A.
        Monocytes are major players in the prognosis and risk of infection after acute stroke.
        Stroke. 2009; 40: 1262-1268